Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia

Kidney International

Volumn 62, Issue 5, 2002, Pages 1582-1590

  Daschner, Markus ^a,b,c   Philippin, Bärbel ^a,b,c   Nguyen, Trang ^a,b,c   Wiesner, Rudolf J ^a,b,c   Walz, Claudia ^a,b,c   Oh, Jun ^a,b,c   Sandow, Jürgen ^a,b,c   Mehls, Otto ^a,b,c   Schaefer, Franz ^a,b,c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Cell culture model; Hypothalamus; Luteinizing hormone; Neuroendocrine defect; Uremic hypogonadism; Uremic toxins

Indexed keywords

CREATININE; ELECTROLYTE; GONADORELIN; HORMONE INHIBITOR; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; PEPTIDE HORMONE; TESTOSTERONE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LINE; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HORMONE RELEASE; HYPOPHYSIS CELL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INCUBATION TIME; LIPID BLOOD LEVEL; MALE; MOLECULAR WEIGHT; NEPHRECTOMY; NERVE CELL; NEUROSECRETION; NONHUMAN; NORTHERN BLOTTING; PLASMA; PRIORITY JOURNAL; RAT; UREMIA;

EID: 0036404946     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00616.x     Document Type: Article

References (60)

1. Schärer K, Schaefer F, Trott M, et al: Pubertal development in children with chronic renal failure, in Growth and Endocrine Changes in Children and Adolescents with Chronic Renal Failure Pediatric and Adolescent Endocrinology, edited by Schärer K, Basel, Karger, 1989, pp 151-168
2. Briefel G, Tsitouras P, Kowatch M, et al: Decreased in vitro testosterone production by isolated cells from uremic rats. Endocrinology 110:976-981, 1982
3. Blackman M, Briefel G, Tsitouras P, Harman S: Excess in vitro secretion of the free alpha-subunit of the glycoprotein hormones by pituitary cells from chronically uremic rats. Endocrinology 110:1964-1971, 1982
4. Nazian SJ, Dietz JR, Rowland MD: Pituitary response to LHRH during chronic renal insufficiency in the male rat. J Andro 110:174-179, 1989
5. Handelsman DJ, Spaliviero JA, Turtle JR: Testicular function in experimental uremia. Endocrinology 117:1974-1983, 1985
6. Holdsworth S, Atkins RC, De Kretser DM: The pituitary-testicular axis in men with chronic renal failure. N Engl J Med 296:1245-1249, 1977
7. Semple C, Beastall G, Henderson I, et al: The pituitary-testicular axis of uraemic subjects on hemodialysis and continuous peritoneal dialysis. Acta Endocrinol 101:464-467, 1982
8. Oertel PJ, Lichtwald K, Häfner S, et al: Hypothalamo-pituitary-gonadal axis in children with chronic renal failure. Kidney Int 24:34-39, 1983
9. Ramirez G, Butcher D, Brueggemeyer CD, Ganguly A: Testicular defect: The primary abnormality in gonadal dysfunction of uremia. South Med J 80:698-701, 1987
10. Dong Q, Handelsman DJ: Hypothalamic opioid mechanisms in experimental uremic hypogonadism. Endocrinology 126:1498-1503, 1990
11. Dong Q, Handelsman DJ: Regulation of pulsatile luteinizing hormone secretion in experimental uremia. Endocrinology 128:1218-1222, 1991
12. Swamy AP, Woolf PD, Cestero RVM: Hypothalamic-pituitary-ovarian axis in uremic women. J Lab Clin Med 93:1066-1072, 1979
13. Rodger RSC, Watson MJ, Sellars L, et al: Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis. Quart J Med 61:1039-1046, 1986
14. Wheatley T, Clark PMS, Raggatt PR, et al: Pulsatility of luteinising hormone in men with chronic renal failure: Abnormal rather than absent. Br Med J 294:482-483, 1987
15. Talbot JA, Rodger RSC, Robertson WR: Pulsatile bioactive luteinising hormone secretion in men with chronic renal failure and following renal transplantation. Nephron 56:66-72, 1990
16. Schaefer F, Seidel C, Mitchell R, et al: Pulsatile immunoreactive and bioactive luteinizing hormone secretion in pubertal patients with chronic renal failure. Pediatr Nephrol 5:566-571, 1991
17. Veldhuis JD, Wilkowski MJ, Zwart AD, et al: Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. J Clin Endocrinol Metab 76:648-654, 1993
18. Schaefer F, Veldhuis JD, Robertson WR, et al: Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney Int 45:1465-1476, 1994
19. Schaefer F, Daschner M, Veldhuis JD, et al: In vivo alterations in the gonadotropin-releasing hormone pulse generator and the secretion and clearance of luteinizing hormone in the castrate uremic rat. Neuroendocrinology 59:285-296, 1994
20. Wibullaksanakul S, Handelsman DJ: Regulation of hypothalamic gonadotropin-releasing hormone secretion in experimental uremia: In vitro studies. Neuroendocrinology 54:353-358, 1991
21. Mellon PL, Windle JJ, Goldsmith PC, et al: Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5:1-10, 1990
22. Weiner RI, Wetsel W, Goldsmith P, et al: Gonadotropin-releasing hormone neuronal cell lines. Front Neuroendocrinol 13:95-119, 1992
23. Turgeon JL, Kimura Y, Waring DW, Mellon PL: Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Mol Endocrinol 10:439-450, 1996
24. Wetsel WC, Valenca MM, Merchenthaler I, et al: Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci USA 89:4149-4153, 1992
25. Silverman AJ, Roberts JL, Dong KW, et al: Intrahypothalamic injection of a cell line secreting gonadotropin-releasing hormone results in cellular differentiation and reversal of hypogonadism in mutant mice. Proc Natl Acad Sci USA 89:10668-10672, 1992
26. Thomas P, Mellon PL, Turgeon J, Waring DW: The L beta T2 clonal gonadotrope: A model for single cell studies of endocrine cell secretion. Endocrinology 137:2979-2989, 1996
27. Mehls O, Ritz E: Skeletal growth in experimental uremia. Kidney Int 24:53-62, 1983
28. Cham BE, Knowles BR: A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 17:176-181, 1976
29. Lasdun A, Reznik S, Molineaux CJ, Orlowski M: Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone. J Pharm Exp Ther 251:439-447, 1989
30. Ellinwood WE, Ronnekleiv OK, Kelly MJ, Resko JA: A new antiserum with conformational specificity for LHRH: Usefulness for radioimmunoassay and immunocytochemistry. Peptides 6:45-52, 1985
31. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
32. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual (2nd ed). Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989
33. Lee D, Park, Yorgin PD, et al: Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79:1376-1382, 1994
34. Romagnoli P, Herzog V: Reinternalization of secretory proteins during membrane recycling in rat pancreatic acinar cells. Eur J Cell Biol 44:167-175, 1987
35. Farquhar MG: Recovery of surface membrane in anterior pituitary cells. Variations in traffic detected with anionic and cationic ferritin. J Cell Biol 77:R35-R42, 1978
36. Christensen EI: Evidence for a decreased membrane recycling in the cells of renal proximal tubules exposed to high concentrations of ferritin. Cell Tissue Res 243:101-108, 1986
37. Hirano N, Tazuma S, Kajiyama G: Transcytotic vesicle fusion with canalicular membranes is modulated by phospholipid species: Implications for biliary lipid secretion. J Gastroenterol Hepatol 12:534-539, 1997
38. Sundler R, Papahadjopoulos D: Control of membrane fusion by phospholipid head groups. I. Phosphatidate/phosphatidylinositol specificity. Biochim Biophys Acta 649:743-750, 1981
39. Asayama K, Ito H, Nakahara C, et al: Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation. Pediatr Res 18:783-788, 1984
40. Avram MM, Fein PA, Antignani A, et al: Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 87:555-560, 1989
41. Saito A, Takagi T, Chung TG, Ohta K: Serum levels of polyamines in patients with chronic renal failure. Kidney Int 24(Suppl 16):S234-S237, 1983
42. De Deyn PP, Marescau B, D'Hooge R, et al: Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27:227-237, 1995
43. Gilad GM, Gilad VH: Treatment with polyamines can prevent monosodium glutamate neurotoxicity in the rat retina. Life Sci 44:1963-1969, 1989
44. Dornay M, Gilad VH, Shiler I, Gilad GM: Early polyamine treatment accelerates regeneration of rat sympathetic neurons. Exp Neurol 92:665-674, 1986
45. Gilad GM, Gilad VH: Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain. Exp Neurol 111:349-355, 1991
46. D'Hooge R, Pei YQ, Marescau B, De Deyn PP: Convulsive action and toxicity of uremic guanidino compounds: Behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112:96-105, 1992
47. Lei ZM, Rao CV, Kornyei JL, et al: Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132:2262-2270, 1993
48. Lei ZM, Rao CV: Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons. Mol Endocrinol 8:1111-1121, 1994
49. Harvey S, Hayer S, Sloley BD: Parathyroid hormone-induced dopamine turnover in the rat medial basal hypothalamus. Peptides 14:269-274, 1993
50. Akmal M, Goldstein DA, Kletzky OA, Massry SG: Hyperparathyreoidism and hypotestosteronemia of acute renal failure. Am J Nephrol 8:166-169, 1988
51. Tönshoff B, Blum WF, Mehls O: Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with end-stage renal failure. Pediatr Nephrol 10:269-274, 1996
52. Longo KM, Sun Y, Gore AC: Insulin-like growth factor-I effects on gonadotropin-releasing hormone biosynthesis in GT1-7 cells. Endocrinology 139:1125-1132, 1998
53. Zamorano PL, Mahesh VB, De Sevilla LM, et al: Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. Neuroendocrinology 65:223-228, 1997
54. Daschner M, Tönshoff B, Blum WF, et al: Inappropriate elevation of serum leptin levels in children with chronic renal failure. J Am Soc Nephrol 9:1074-1079, 1998
55. Schaefer RM, Kokot F, Wernze H, et al: Improved sexual function in hemodialysis patients on recombinant erythropoietin: A possible role for prolactin. Clin Nephrol 31:1-5, 1989
56. Prince RL, Hutchison BG, Kent JC, et al: Calcitriol deficiency with retained synthetic reserve in chronic renal failure. Kidney Int 33:722-728, 1988
57. 3 on the female reproductive system in rats. J Toxicol Sci 17:91-105, 1992
58. Samaan NA, Freeman RM: Growth hormone levels in severe renal failure. Metabolism 19:102-113, 1970
59. Lacour B, Roullet JB, Bluet-Pajot MT, et al: Plasma and pituitary content of growth hormone luteinizing hormone, and prolactin in uremic rats. Effects of chronic infusion of insulin. Nephron 44:235-239, 1986
60. Milenkovic L, D'Angelo G, Kelly PA, Weiner RI: Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. Proc Natl Acad Sci USA 91:1244-1247, 1994